Full Press Release Details
Allogene Therapeutics Publishes Preclinical Data in Clinical Cancer Research Supporting DLL3 as a Potential AlloCAR T Target for Small Cell Lung Cancer.
ALLO
Allogene Therapeutics Publishes Preclinical Data in Clinical Cancer Research Supporting DLL3 as a Potential AlloCAR T Target for Small Cell Lung Cancer
Key Takeaway: Allogene Therapeutics Publishes Preclinical Data in Clinical Cancer Research Supporting DLL3 as a Potential AlloCAR T Target for Small Cell Lung Cancer